Update on oxygen radical disease in neonatology

Current Opinion in Obstetrics and Gynecology

Volumn 13, Issue 2, 2001, Pages 147-153

  Saugstad, Ola Didrik ^a,b  

^a UNIVERSITY OF OSLO   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

OXYGEN RADICAL; REACTIVE OXYGEN METABOLITE;

CHRONIC LUNG DISEASE; LEUKOMALACIA; NECROTIZING ENTEROCOLITIS; NEWBORN DISEASE; OXIDATIVE STRESS; PREMATURITY; PRIORITY JOURNAL; RETINOPATHY; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; ANTIOXIDANTS; BRONCHOPULMONARY DYSPLASIA; CHRONIC DISEASE; ENTEROCOLITIS, NECROTIZING; GLUTATHIONE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE, DISEASES; LEUKOMALACIA, PERIVENTRICULAR; LUNG DISEASES; NITRIC OXIDE; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; RETINOPATHY OF PREMATURITY;

EID: 0034913860     PISSN: 1040872X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001703-200104000-00009     Document Type: Review

References (52)

1. Plasma hypoxanthine levels in newborn infants: A specific indicator of hypoxia
2. Hypoxanthine and oxygen induced lung injury: A basic mechanism of tissue damage?
3. Hypoxanthine as an indicator of hypoxia: Its role in health and disease through free radical production
4. Iron, plasma antioxidants, and the 'oxygen radical disease of prematurity'
5. Chronic lung disease: The role of oxidative stress
6. Vitamin E prophylaxis to reduce retinopathy of prematurity; a reappraisal of published trials
7. Oxidants as stimulators of signal transduction
8. Raised concentrations of aldehyde lipid peroxidation products in premature infants with chronic lung disease
9. Supplemental therapeutic oxygen for pretreshold retinopathy of prematurity (STOP-ROP), a randomized, controlled trial: Primary outcomes
10. Do clinical markers of barotrauma and oxygen toxicity explain interhospital variation in rates of chronic lung disease?
11. Elevated lipid carbonyls and lipid peroxidation products correlating with myeloperoxidase in tracheal aspirates from premature infants
12. Protein carbonyls and lipid peroxidation products as oxidation markers in preterm infant plasma: Associations with chronic lung disease and retinopathy and effects of selenium supplementation
13. Sodium nitroprusside prevents oxygen-free-radical-induced pulmonary vasoconstriction in newborn piglets
14. Lipid peroxidation of lung surfactant by bacteria
15. Oxidants, nitric oxide and prostanoids in the developing ocular vasculature: A basis for ischemic retinopathy
16. High post modern vitreous hypoxanthine levels in newborns with the respiratory distress syndrome
17. Glutathione status in retinopathy of prematurity
18. Plasma chain-breaking antioxidants in preterm infants with good and poor short-term outcome
19. Hypoxanthine as a measurement of hypoxia
20. Plasma xanthine oxidase and lipid hydroperoxide levels in preterm infants
21. Antioxidant capacity and oxygen radical disease in the preterm newborn
22. Hypoxia-induced free iron release in the red cells of the newborn infants
23. Total hydroperoxide and advanced oxidation protein products in preterm hypoxic babies
24. Plasma hypoxanthine levels as a prognostic aid of tissue hypoxia
25. Compressed air as a source of inhaled oxidants in intensive care units
26. Iron supplementation aggravates periventricular cystic white matter lesions in newborn mice
27. Changes in iron histochemistry after hypoxic-ischemic brain injury in the neonatal rat
28. The neuroprotective effect of deferoxamine in the hypoxic-ischemic immature mouse brain
29. Antioxidant protection against iron toxicity: Plasma changes during cardiopulmonary bypass in neonates, infants, and children
30. The free radical spin trap alpha-phenyl-tert-butyl nitrone attenuates the cerebral response to deep hypothermic ischemia
31. Chemiluminescence because of the production of reactive oxygen species in the lungs of newborn piglets during resuscitation periods after asphyxiation load
32. The use of room air ventilation enhances the establishment of a sustained spontaneous respiratory pattern after perinatal asphyxia
33. Inhaled nitric oxide decreases hyperoxia-induced surfactant abnormality in preterm rabbits
34. Nitric oxide and hyperoxia in oxidative lung injury
35. Dose dependency of L-arginine in neonatal myocardial protection: The nitric oxide paradox
36. Reperfusion injury as the mechanism of brain damage after perinatal asphyxia
37. Role of neutrophil-endothelial cell adhesion in inflammatory disorders
38. Oxygen radicals, cytokines, adhesion molecules and lung injury in neonates
39. Serum TNF-alpha and free radical scavengers in neonatal septicemia
40. Redox-sensitive protein phosphatase activity regulates the phosphorylation state of p38 protein kinase in primary astrocyte culture
41. Basal protein phosphorylation is decreased and phosphatase activity increased by an antioxidant and a free radical trap in primary rat glia
42. Release of superoxide dismutase activity from human umbilical veins by heparin
43. Pharmacokinetics of intravenous N-acetylcysteine in pre-term new-born infants
44. Effect of the 21-aminosteroid U74389G on oxygen-induced free radical production, lipid peroxidation, and inhibition of lung growth in neonatal rats
45. Desmethyl tirilazad improves neurologic function after hypoxic ischemic brain injury in piglets
46. Endogenous glutathione protects cerebral endothelial cells from traumatic injury
47. Effect of barbiturates on hydroxyl radicals, lipid peroxidation, and hypoxic cell death in human NT2-N neurons
48. Pretreatment with allopurinol in cardiac hypoxic-ischemic reperfusion injury in newborn lambs exerts its beneficial effect through afterload reduction
49. Effect of deferoxamine on post-hypoxic-ischemic reperfusion injury of the newborn lamb heart
50. Chinonin, a novel drug against cardiomyocyte apoptosis induced by hypoxia and reoxygenation
51. Effects of CP-060S, a novel Ca(2+) channel blocker, on oxidative stress in cultured cardiac myocytes